Table 6.
CYP SUBSTRATE | mouse | Hepatic P450 Activities (nmol/mg microsomal protein/min) | |||
---|---|---|---|---|---|
Treatment 2 | Treatment 3 | Treatment 4 | Treatment 5 | ||
Fe-diet | Fe-diet ala/fedex | Fe-diet pcb/ala | Fe-diet pcb/ala/fedex | ||
7-methoxyresorufin | |||||
#1 | 0.025 | 0.020 | 0.828 | 0.263 | |
#2 | 0.029 | 0.020 | 1.018 | 1.099 | |
#3 | 0.015 | - | 1.142 | 0.861 | |
#4 | 0.020 | 0.026 | 1.518 | 1.147 | |
#5 | 0.014 | 1.216 | |||
#6 | 0.027 | 1.133 | |||
7-ethoxyresorufin | |||||
#1 | 0.100 | 0.056 | 2.259 | 1.119 | |
#2 | 0.144 | 0.078 | 3.269 | 3.429 | |
#3 | 0.063 | 0.052 | 3.594 | 2.609 | |
#4 | 0.113 | 0.106 | 5.060 | 4.051 | |
#5 | 0.051 | 4.106 | |||
#6 | 0.085 | 3.858 | |||
7-ethoxy-4-trifluoro methylcoumarin | |||||
#1 | 0.573 | 0.274 | 3.692 | 1.678 | |
#2 | 0.605 | 0.327 | 3.970 | 4.221 | |
#3 | 0.481 | 0.386 | 4.202 | 3.987 | |
#4 | 0.455 | 0.389 | 5.994 | 4.795 | |
#5 | 0.354 | 4.209 | |||
#6 | 0.457 | 4.386 | |||
7-pentoxyresorufin | |||||
#1 | 0.049 | 0.043 | 0.051 | 0.065 | |
#2 | 0.053 | 0.039 | 0.050 | 0.065 | |
#3 | 0.039 | 0.046 | 0.048 | 0.044 | |
#4 | 0.046 | 0.025 | 0.060 | 0.048 | |
#5 | 0.041 | 0.053 | |||
#6 | 0.040 | 0.051 | |||
7-benzyloxy quinoline | |||||
#1 | 0.719 | 0.462 | 0.418 | 0.229 | |
#2 | 0.701 | 0.413 | 0.605 | 0.608 | |
#3 | 0.520 | 0.430 | 0.560 | 0.369 | |
#4 | 0.484 | 0.446 | 0.956 | 0.609 | |
#5 | 0.322 | 0.624 | |||
#6 | 0.529 | 0.699 |
Mice fed a high iron diet (fe-diet, 2 mg Fe/g) after weaning > 14 weeks and were sacrificed 4 weeks after receiving any of additional treatments indicated. “Fedex” was a single injection of aqueous iron dextran (10 mg, ip), “ala” was δ-aminolevulinic acid (2 mg/ml) provided continuously in the drinking water and “pcb” was a single injection of Aroclor 1254, (4 mg, ip in corn oil). Values for animals are arranged in the same order as the male Cyp1a2−/− Hfe−/− Urod+/− group in Table 2.